GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Vineet Laboratories Ltd

Vineet Laboratories: MD Gaddam Venkata Ramana Ceases Office

MANAGEMENT ◆ Monitor Closely LOW RISK
📅 Filed on BSE: 21 Jul 2026, 10:16 PM IST  ·  BSE ID: afc29f59-34f9-43ca-9b70-34b7b59c53f8
View Original BSE Filing (PDF)
💡
In Simple Terms
Vineet Laboratories' Managing Director has stepped down, but remains on the board.
🤖 AI Summary
  • Mr. Gaddam Venkata Ramana has ceased to hold the office of Managing Director.
  • The cessation is effective from July 21, 2026.
  • He will continue to hold office as a Director of the company.
  • This event follows the recent appointment of Rajesh Kumar Kathulla as an Executive Director.
🏢 How This Affects the Company
⚙️
Operational Impact
The departure of the Managing Director may lead to a realignment of leadership responsibilities and strategic direction within the company.
⚠️
Risk Impact
A change in top management, while the individual remains a director, could introduce a period of adjustment for internal operations and strategic continuity.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders.
👤
Who Is Affected
All shareholders are informed of this executive management change.
🔍
Management Signal
The management is signaling a transition in the executive leadership role while retaining directorial oversight.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Further board meeting minutes for strategic shifts.
Subsequent company announcements regarding leadership roles.
Operational performance updates post-transition.
LOW RISK The individual continues as a director, mitigating immediate governance or strategic risk.
💡 Investor Takeaway
Mr. Gaddam Venkata Ramana has ceased as Managing Director of Vineet Laboratories effective July 21, 2026, but continues as a Director.
❓ Frequently Asked Questions
Who has ceased to be the Managing Director of Vineet Laboratories?
Mr. Gaddam Venkata Ramana (DIN: 00031873) has ceased to hold the office of Managing Director.
When did Mr. Gaddam Venkata Ramana's cessation as MD take effect?
The cessation is effective from July 21, 2026.
Does Mr. Gaddam Venkata Ramana continue to hold any position at Vineet Laboratories?
Yes, Mr. Gaddam Venkata Ramana continues to hold office as a Director of the Company.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.